IVD

We are an EN ISO 13485 certified EU-located company developing and producing CE IVD real-time PCR kits.

Our in vitro diagnostics fall into five categories: clinical genetics, hematology, pharmacogenetics, oncology and microbiology.

Our typical partners are end-users of the RT-PCR kits (mostly in CZ and SK), business partners and distributors. We are looking for business partners and/or distributors worldwide who can fit the portfolio of our products, either the whole or a part of it, to their sales strategy (see here).

Tiles List

gb PHARM DPYD

The CE IVD kit is used for determination of genotype of four polymorphisms according to guidelines CPIC and DPWG: *2A (c1905+1G>A), *13 (c1679T>G), HapB3 (c1236G>A) and c2846A>T in human genomic DNA. The principle of detection is based on real-time PCR with fluorescently labelled probes (allelic discrimination).

New

gb PHARM BCHE

The CE IVD kit is used for determination of genotype of five polymorphisms: A (D70G, rs1799807), K (A539T, rs1803274), F1 (T243M, rs28933389), F2 (G390V, rs28933390), S1 (FS117, rs398124632) in human genomic DNA.

New

gb ONCO EGFR

The gb ONCO EGFR diagnostic kit is used to identify mutations in exons 18, 19, 20 and 21 of the EGFR gene in patients with oncological disease. The detection principal is based on real-time PCR using fluorescently labelled probes, allele-specific primers and PCR blockers. The kit contains 3 specific assays and the corresponding Master Mix for the detection of 7 EGFR gene mutation groups and for a total of 40 individual mutations. The kit contains all the necessary components to perform the analysis.